Gaurav Shah - 21 Feb 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol
RCKT
Transactions as of
21 Feb 2025
Net transactions value
-$172,486
Form type
4
Filing time
25 Feb 2025, 16:01:53 UTC
Previous filing
13 Feb 2025
Next filing
14 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $172,486 -16,303 -2.1% $10.58 772,680 21 Feb 2025 Direct F1, F2
holding RCKT Common Stock 207,897 21 Feb 2025 By Spouse
holding RCKT Common Stock 198,341 21 Feb 2025 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.